ReviewBritish journal of pharmacology2015

Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes.

Mitchel Tate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.